Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment
- Conditions
- Panic DisorderAnxiety, SocialDepression Moderate
- Interventions
- Behavioral: eMeistring
- Registration Number
- NCT05868135
- Lead Sponsor
- St. Olavs Hospital
- Brief Summary
The goal of this observational multicentre study is to address the effectiveness and cost-effectiveness of providing a therapist guided internet based cognitive behavioural therapy (ICBT) for common mental disorders in a routine healthcare setting.
Main research questions is 1) What is the effectiveness of guided internet based treatment for moderate depression, panic disorder and social anxiety disorder across clinics in routine care? 2) What is the cost-effectiveness of guided internet based treatment for moderate depression, panic disorder and social anxiety disorder across clinics? 3) Who benefits from guided internet-delivered treatment? 4) What are the predictors of drop-out from guided internet based treatment? 5) To what extent does user experiences of guided internet based treatment influence adherence and effectiveness? Participants will receive up to nine guided ICBT sessions (modules) and answer questionnaires covering symptoms severity, health related quality of life, work and social ability, user satisfaction and medication. All questionnaires are part of the standard patient follow up routines in the four treatment locations participating in the study. Analytical approach is to compare locations/clinics and subgroups of patients.
- Detailed Description
The therapist guided internet based cognitive therapy (ICBT) cover moderate depression, social anxiety disorder (SAC) and panic disorder (PD).
The eMeistring-program is standard treatment in all four hospitals/locations participating in the study. Patients are recruited through the ordinary clinical patient pathways. After a pre-treatment assessment, an initial face-to-face visit takes place (T1). Patients are given the opportunity to participate in the study based on informed concent. Next, participants in the depression program will receive eight guided internet based cognitive behavioural therapy sessions or modules. Similarly SAC and PD patients will receive nine modules. Therapist guidance are provided at least once a week via a secure email system. When sessions are finished (T2), a new face-to-face visit with the therapist is offered.
Therapists are licensed health personnel e.g. psychologists, registered nurses and clinical social workers, working in the clinics.
Administrative data about covering organizational implementation of the eMeistring treatment program, personnel involved and level of treatment activity is collected separately.
Inclusion criteria's for eMeistring therapy: having moderate depression, panic disorder and social anxiety disorder as a primary disorder, and having computer and internet access.
Exclusion criteria: severe depression, suicidal impulses and thoughts, bipolar disorders, psychosis, substance abuse, unstable medication last month), severe reading or writing disabilities.
Adverse events are taken care of through routine follow-up according to the outpatient clinic responsibility. Any responses from patients indicating suicidal behaviour triggers email to the therapist with an urge to follow-up.
Planned statistical analyses include multivariate analyses of effectiveness (intention-to-treat and completers), predictor analyses of drop-out and adherence, and cost-effectiveness analyses based on health related quality of life, intervention costs and other health care and societal costs, analysing location specific differences stratified by patient groups.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 800
Having moderate depression, panic disorder and social anxiety disorder as a primary disorder. Access to computer and internet.
Having severe depression, suicidal impulses and thoughts, bipolar disorders, psychosis, substance abuse, unstable medication last month, severe reading or writing disabilities.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with moderate depression eMeistring - Patients with social anxiety disorder eMeistring - Patients with panic disorder eMeistring -
- Primary Outcome Measures
Name Time Method Panic disorder symptoms Pre treatment (T1), up to 14 weeks after treatment start (T2), six months after T2 (T3) and after two years (T4) For panic disorder group: Panic disorder disorder symptoms assessed by PDSS-SR, Panic Disorder Severity Scale. Minimum raw score: 0, maximum raw score: 28. Composite scores range from 0-4. The composite score is the average of the seven items. Higher score indicates higher severity of panic disorder.
Depression severity Pre treatment (T1), up to 14 weeks after treatment start (T2), six months after T2 (T3) and after two years (T4) For moderate depression group: Depression severity assessed by PHQ-9, Patient Health Questionnaire score. Minimum score is 0, maximum score is 27. Higher score indicates more severe depression
Social phobia Pre treatment (T1), up to 14 weeks after treatment start (T2), six months after T2 (T3) and after two years (T4) For social anxiety group: Social Phobia assessed by SPIN, Social Phobia Inventory score. Minimum score is 0, maximum score is 68. Higher score indicates more severe phobia.
- Secondary Outcome Measures
Name Time Method Depression severity Pre treatment (T1), up to 14 weeks after treatment start (T2), six months after T2 (T3) and after two years (T4) For social anxiety group an panic disorder group: Depression severity assessed by PHQ-9, Patient Health Questionnaire score. Minimum score is 0, maximum score is 27. Higher score indicates more severe depression
System Usability Up to 14 weeks after treatment start (T2) For all patients: System usability will be assessed by the System Usability Scale Score. Minimum score is 0, maximum score is 100. Higher SUS scores indicate better usability.
Cost of health care services Period between pre treatment (T1) and up to 14 weeks after treatment start (T2), and to six months after post treatment (T3) and until two years (T4) Cost of health care services calculated as sum costs for hospital inpatient stays plus outpatient visits plus home care visits plus nursing home stays plus general practitioner visits plus physiotherapist visits plus other supportive care visits.
Work participation Pre treatment (T1), up to 14 weeks after treatment start (T2), six months after post treatment (T3) and after two years (T4) Work participation assessed by questionnaire: Currently employed or not.
Medication Pre treatment (T1), up to 14 weeks after treatment start (T2), six months after T2 (T3) and after two years (T4) Patient reported use of medication, assessed by a separate questionnaire.
Sickness absenteeism Pre treatment (T1), up to 14 weeks after treatment start (T2), six months after post treatment (T3) and after two years (T4) Sickness absenteeism assessed by questionnaire: Number of days absent the last four weeks.
Health Related Quality of Life Pre treatment (T1), up to 14 weeks after treatment start (T2), six months after T2 (T3) and after two years (T4) For all patients: Health related quality of life assessed by EQ-5D-5L index score, EuroQol-5Dimension-5Level index score. Minimum score is 0, maximum score is 1. Higher score indicates higher health related quality of life.
Work and social adjustment Pre treatment (T1), up to 14 weeks after treatment start (T2), six months after T2 (T3) and after two years (T4) For all patients: Work and social adjustment assessed by Work and Social Adjustment Scale score. Minimum score is 0, maximum score is 40. Higher score indicates worse level of social functioning.
Anxiety severity Pre treatment (T1), up to 14 weeks after treatment start (T2), six months after T2 (T3) and after two years (T4) For all patients: Anxiety severity will be assessed by GAD-7, Generalized Anxiety Disorder 7-item score. Minimum score is 0, maximum score is 21. Higher score indicates more severe anxiety.
Trial Locations
- Locations (4)
Sykehuset Innlandet HF
🇳🇴Lillehammer, Norway
Sykehuset i Vestfold HF
🇳🇴Tønsberg, Norway
St. Olavs Hospital HF
🇳🇴Trondheim, Norway
Helse Bergen HF
🇳🇴Bergen, Norway